A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.

Serological assays for human IgG4 to the Onchocerca volvulus antigen Ov16 have been used to confirm elimination of onchocerciasis in much of the Americas and parts of Africa. A standardized source of positive control antibody (human anti-Ov16 IgG4) will ensure the quality of surveillance data using...

Full description

Bibliographic Details
Published in:PLOS Neglected Tropical Diseases
Main Authors: Allison Golden, Eric J Stevens, Lindsay Yokobe, Dunia Faulx, Michael Kalnoky, Roger Peck, Melissa Valdez, Cathy Steel, Potochoziou Karabou, Méba Banla, Peter T Soboslay, Kangi Adade, Afework H Tekle, Vitaliano A Cama, Peter U Fischer, Thomas B Nutman, Thomas R Unnasch, Tala de los Santos, Gonzalo J Domingo
Format: Article in Journal/Newspaper
Language:English
Published: Public Library of Science (PLoS) 2016
Subjects:
Online Access:https://doi.org/10.1371/journal.pntd.0004292
https://doaj.org/article/fc119ed08a81444787e314d1af42cc83
id ftdoajarticles:oai:doaj.org/article:fc119ed08a81444787e314d1af42cc83
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:fc119ed08a81444787e314d1af42cc83 2023-05-15T15:16:10+02:00 A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus. Allison Golden Eric J Stevens Lindsay Yokobe Dunia Faulx Michael Kalnoky Roger Peck Melissa Valdez Cathy Steel Potochoziou Karabou Méba Banla Peter T Soboslay Kangi Adade Afework H Tekle Vitaliano A Cama Peter U Fischer Thomas B Nutman Thomas R Unnasch Tala de los Santos Gonzalo J Domingo 2016-01-01T00:00:00Z https://doi.org/10.1371/journal.pntd.0004292 https://doaj.org/article/fc119ed08a81444787e314d1af42cc83 EN eng Public Library of Science (PLoS) http://europepmc.org/articles/PMC4706346?pdf=render https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0004292 https://doaj.org/article/fc119ed08a81444787e314d1af42cc83 PLoS Neglected Tropical Diseases, Vol 10, Iss 1, p e0004292 (2016) Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2016 ftdoajarticles https://doi.org/10.1371/journal.pntd.0004292 2022-12-31T01:09:27Z Serological assays for human IgG4 to the Onchocerca volvulus antigen Ov16 have been used to confirm elimination of onchocerciasis in much of the Americas and parts of Africa. A standardized source of positive control antibody (human anti-Ov16 IgG4) will ensure the quality of surveillance data using these tests.A recombinant human IgG4 antibody to Ov16 was identified by screening against a synthetic human Fab phage display library and converted into human IgG4. This antibody was developed into different positive control formulations for enzyme-linked immunosorbent assay (ELISA) and rapid diagnostic test (RDT) platforms. Variation in ELISA results and utility as a positive control of the antibody were assessed from multiple laboratories. Temperature and humidity conditions were collected across seven surveillance activities from 2011-2014 to inform stability requirements for RDTs and positive controls. The feasibility of the dried positive control for RDT was evaluated during onchocerciasis surveillance activity in Togo, in 2014. When the anti-Ov16 IgG4 antibody was used as a standard dilution in horseradish peroxidase (HRP) and alkaline phosphatase (AP) ELISAs, the detection limits were approximately 1ng/mL by HRP ELISA and 10ng/mL by AP ELISA. Positive control dilutions and spiked dried blood spots (DBS) produced similar ELISA results. Used as a simple plate normalization control, the positive control antibody may improve ELISA data comparison in the context of inter-laboratory variation. The aggregate temperature and humidity monitor data informed temperature parameters under which the dried positive control was tested and are applicable inputs for testing of diagnostics tools intended for sub-Saharan Africa. As a packaged positive control for Ov16 RDTs, stability of the antibody was demonstrated for over six months at relevant temperatures in the laboratory and for over 15 weeks under field conditions.The recombinant human anti-Ov16 IgG4 antibody-based positive control will benefit inter-laboratory validation ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic PLOS Neglected Tropical Diseases 10 1 e0004292
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Allison Golden
Eric J Stevens
Lindsay Yokobe
Dunia Faulx
Michael Kalnoky
Roger Peck
Melissa Valdez
Cathy Steel
Potochoziou Karabou
Méba Banla
Peter T Soboslay
Kangi Adade
Afework H Tekle
Vitaliano A Cama
Peter U Fischer
Thomas B Nutman
Thomas R Unnasch
Tala de los Santos
Gonzalo J Domingo
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
topic_facet Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
description Serological assays for human IgG4 to the Onchocerca volvulus antigen Ov16 have been used to confirm elimination of onchocerciasis in much of the Americas and parts of Africa. A standardized source of positive control antibody (human anti-Ov16 IgG4) will ensure the quality of surveillance data using these tests.A recombinant human IgG4 antibody to Ov16 was identified by screening against a synthetic human Fab phage display library and converted into human IgG4. This antibody was developed into different positive control formulations for enzyme-linked immunosorbent assay (ELISA) and rapid diagnostic test (RDT) platforms. Variation in ELISA results and utility as a positive control of the antibody were assessed from multiple laboratories. Temperature and humidity conditions were collected across seven surveillance activities from 2011-2014 to inform stability requirements for RDTs and positive controls. The feasibility of the dried positive control for RDT was evaluated during onchocerciasis surveillance activity in Togo, in 2014. When the anti-Ov16 IgG4 antibody was used as a standard dilution in horseradish peroxidase (HRP) and alkaline phosphatase (AP) ELISAs, the detection limits were approximately 1ng/mL by HRP ELISA and 10ng/mL by AP ELISA. Positive control dilutions and spiked dried blood spots (DBS) produced similar ELISA results. Used as a simple plate normalization control, the positive control antibody may improve ELISA data comparison in the context of inter-laboratory variation. The aggregate temperature and humidity monitor data informed temperature parameters under which the dried positive control was tested and are applicable inputs for testing of diagnostics tools intended for sub-Saharan Africa. As a packaged positive control for Ov16 RDTs, stability of the antibody was demonstrated for over six months at relevant temperatures in the laboratory and for over 15 weeks under field conditions.The recombinant human anti-Ov16 IgG4 antibody-based positive control will benefit inter-laboratory validation ...
format Article in Journal/Newspaper
author Allison Golden
Eric J Stevens
Lindsay Yokobe
Dunia Faulx
Michael Kalnoky
Roger Peck
Melissa Valdez
Cathy Steel
Potochoziou Karabou
Méba Banla
Peter T Soboslay
Kangi Adade
Afework H Tekle
Vitaliano A Cama
Peter U Fischer
Thomas B Nutman
Thomas R Unnasch
Tala de los Santos
Gonzalo J Domingo
author_facet Allison Golden
Eric J Stevens
Lindsay Yokobe
Dunia Faulx
Michael Kalnoky
Roger Peck
Melissa Valdez
Cathy Steel
Potochoziou Karabou
Méba Banla
Peter T Soboslay
Kangi Adade
Afework H Tekle
Vitaliano A Cama
Peter U Fischer
Thomas B Nutman
Thomas R Unnasch
Tala de los Santos
Gonzalo J Domingo
author_sort Allison Golden
title A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
title_short A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
title_full A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
title_fullStr A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
title_full_unstemmed A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
title_sort recombinant positive control for serology diagnostic tests supporting elimination of onchocerca volvulus.
publisher Public Library of Science (PLoS)
publishDate 2016
url https://doi.org/10.1371/journal.pntd.0004292
https://doaj.org/article/fc119ed08a81444787e314d1af42cc83
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source PLoS Neglected Tropical Diseases, Vol 10, Iss 1, p e0004292 (2016)
op_relation http://europepmc.org/articles/PMC4706346?pdf=render
https://doaj.org/toc/1935-2727
https://doaj.org/toc/1935-2735
1935-2727
1935-2735
doi:10.1371/journal.pntd.0004292
https://doaj.org/article/fc119ed08a81444787e314d1af42cc83
op_doi https://doi.org/10.1371/journal.pntd.0004292
container_title PLOS Neglected Tropical Diseases
container_volume 10
container_issue 1
container_start_page e0004292
_version_ 1766346463546179584